Products for Research Use Only
RegisterLogin

Frovatriptan succinate hydrate

CAT: 0931-T11326-01Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T11326-01Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
158930-17-7
Target
5-HT Receptor
Related Pathways
GPCR/G Protein, Neuroscience
Purity
0.9995
Bioactivity
Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.
Smiles
O.OC(=O)CCC(O)=O.CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O
Molecular Formula
C18H25N3O6
Molecular Weight
379.41
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Frovatriptan Succinate

Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05)

CAS Number158930-17-7
PubChem CID152943
IUPAC Namebutanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
Molecular FormulaC18H25N3O6
Molecular Weight379.4
Topological Polar Surface Area147
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Heavy Atom Count27
Formal Charge0
Complexity426
SMILES
CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
InChI
InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1
InChIKey
CUETXFMONOSVJA-KLQYNRQASA-N
Chemical Structure
2D Structure
2D structure of Frovatriptan Succinate
CAS: 158930-17-7
CID: 152943
Formula: C18H25N3O6
MW: 379.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight379.4
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass379.17433553
Monoisotopic Mass379.17433553
Topological Polar Surface Area147 Ų
Heavy Atom Count27
Formal Charge0
Complexity426
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes

Related Products

CatalogName
T21407-01Frovatriptan Succinate
T15731-01Ribociclib succinate hydrate
T6188-01Desvenlafaxine succinate hydrate
T60345-01Frovatriptan
T67915-01Succinate/succinate receptor antagonist 1
TYD-01440-01Diammonium succinate
T72749-01E7090 succinate
T71897-01Vatalanib succinate
T11824Lanraplenib succinate
T7875-01Emoxypine Succinate

Alternative Products

CatalogName
MBS5753144Frovatriptan succinate hydrate
HY-B1658A-01Frovatriptan (succinate hydrate)
HY-B1658ARFrovatriptan (succinate hydrate) (Standard)
HY-B1658BFrovatriptan (succinate)
S5848-25mgFrovatriptan Succinate
012638Frovatriptan Succinate Monohydrate

Popular Products